| MeSH term | MeSH ID | Detail |
|---|---|---|
| Vision Disorders | D014786 | 10 associated lipids |
| Multiple Myeloma | D009101 | 13 associated lipids |
| Osteoporosis | D010024 | 12 associated lipids |
| Kidney Diseases | D007674 | 29 associated lipids |
| Weight Gain | D015430 | 101 associated lipids |
| Otosclerosis | D010040 | 2 associated lipids |
| Cardiovascular Diseases | D002318 | 24 associated lipids |
| Hypersensitivity, Delayed | D006968 | 43 associated lipids |
| Glioma | D005910 | 112 associated lipids |
| Calcinosis | D002114 | 5 associated lipids |
7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Schinke T et al. | Molecular determinants of arterial calcification. | 1998 | Ann. Med. | pmid:9920355 |
| Akatsu T et al. | Osteoclastogenesis inhibitory factor exhibits hypocalcemic effects in normal mice and in hypercalcemic nude mice carrying tumors associated with humoral hypercalcemia of malignancy. | 1998 | Bone | pmid:9855457 |
| Murakami T et al. | Transforming growth factor-beta1 increases mRNA levels of osteoclastogenesis inhibitory factor in osteoblastic/stromal cells and inhibits the survival of murine osteoclast-like cells. | 1998 | Biochem. Biophys. Res. Commun. | pmid:9837778 |
| Yun TJ et al. | OPG/FDCR-1, a TNF receptor family member, is expressed in lymphoid cells and is up-regulated by ligating CD40. | 1998 | J. Immunol. | pmid:9834095 |
| Vidal NO et al. | Osteoprotegerin mRNA is expressed in primary human osteoblast-like cells: down-regulation by glucocorticoids. | 1998 | J. Endocrinol. | pmid:9795357 |
| Horwood NJ et al. | Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprotegerin in osteoblastic stromal cells. | 1998 | Endocrinology | pmid:9794488 |
| Hakeda Y et al. | Osteoclastogenesis inhibitory factor (OCIF) directly inhibits bone-resorbing activity of isolated mature osteoclasts. | 1998 | Biochem. Biophys. Res. Commun. | pmid:9790989 |
| Hofbauer LC et al. | Osteoprotegerin production by human osteoblast lineage cells is stimulated by vitamin D, bone morphogenetic protein-2, and cytokines. | 1998 | Biochem. Biophys. Res. Commun. | pmid:9784422 |
| Filvaroff E and Derynck R | Bone remodelling: a signalling system for osteoclast regulation. | 1998 | Curr. Biol. | pmid:9768352 |
| Takai H et al. | Transforming growth factor-beta stimulates the production of osteoprotegerin/osteoclastogenesis inhibitory factor by bone marrow stromal cells. | 1998 | J. Biol. Chem. | pmid:9765225 |